No. As of September 2026, Humana Inc. (HUM) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 25.6% / 30% · (Cash+Inv) / Mkt Cap (36m) 54.0% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 25.6% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 51.5% / 33% · Receivables / Mkt Cap (36m) 5.88% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 25.6% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 51.5% / 33.33% · Receivables / Mkt Cap (24m) 5.88% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 24.4% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 34.4% / 33.33% · Receivables / Avg Assets (4Q) 7.80% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 21.8% / 33.33% · (Cash+ST Inv) / Total Assets 43.8% / 33.33% · (Cash+Recv) / Total Assets 48.8% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
No. As of September 2026, Humana Inc. (HUM) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. Humana Inc. is over the AAOIFI limit on (Cash+Inv) / Mkt Cap (36m).
Humana Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.
Humana Inc. (NYSE: HUM) is a Healthcare company (Medical - Healthcare Plans) with a market capitalization of $53.3B. The Maz Rating grades it against the other companies in its sector.
Humana Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $443.43, Humana Inc. trades at 42.5x trailing earnings, 0.3x sales and 2.8x book value, with an EV/EBITDA of 18.2. Over the last twelve months it generated about $155.0B of revenue and $1.3B of net income. It runs a gross margin of 13.0%, an operating margin of 1.3% and a net margin of 0.8%. It shows return on equity of 6.7%, return on invested capital of 4.4% and a free cash flow yield of 1.4%. On the balance sheet: a debt-to-equity ratio of 0.66 and a current ratio of 1.65. Over the past 52 weeks the share price ranged from $163.11 to $462.87, with a beta of 0.74.
Humana Inc. pays a dividend yielding 0.80%, with 34% of earnings paid out. Its Maz Dividend Score is 1.50 out of 5, ranked against the other dividend payers in its sector (Safety 2.10, Growth 3.43, Yield 1.90, Consistency 2.32).
44 Wall Street analyst ratings cover the stock: 21 Buy, 22 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.